Pancreatic Cancer Research

ResearcherNagoya University HospitalNo recent work listed

Takashi Shibata

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6459-5440; OpenAlex author ID A5080006264. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 1 paper

Papers 2

  1. Optimal dose of gemcitabine for the treatment of biliary tract or pancreatic cancer in patients with liver dysfunction. Co-author DOI 10.1111/cas.12851↗
  2. [Multicenter phase II study of pre-administered uracil/tegafur (UFT) plus gemcitabine for unresectable/recurrent pancreatic cancer]. Co-author PMID 21566438↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yukio Ando · 1 shared paper, 2016 · strength 0.06
  2. Masato Nagino · 1 shared paper, 2016 · strength 0.06
  3. Ken-Ichi Fujita · 1 shared paper, 2016 · strength 0.06
  4. Yasutsuna Sasaki · 1 shared paper, 2016 · strength 0.06
  5. Osamu Maeda · 1 shared paper, 2016 · strength 0.06
  6. Tomoki Ebata · 1 shared paper, 2016 · strength 0.06
  7. Shoji Nakamori · 1 shared paper, 2011 · strength 0.02
  8. Morito Monden · 1 shared paper, 2011 · strength 0.02
  9. Masaki Mori · 1 shared paper, 2011 · strength 0.02
  10. Yuichiro Doki · 1 shared paper, 2011 · strength 0.02
  11. Yutaka Takeda · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.